The COVID-19 pandemic poses unprecedented challenges for communities around the world. As the virus continues to spread, COVID-19 is having severe public health and economic effects and has created urgent funding needs worldwide.
To help funders make immediate and strategic investments, Gladstone Institutes and Give2Asia hosted a webinar to provide insight into the pandemic. This webinar combines the biomedical research perspective with recommendations on the difference philanthropy can make in both this and future pandemics.
Melanie Ott, MD, PhD, is a senior investigator at Gladstone Institutes. She uses state-of-the-art organoids to model the infected human lung in a dish, and help scientists understand at a single-cell level how the coronavirus damages lung tissue and how to prevent this.
Aqeela Jogee is the vice president of family philanthropy at Give2Asia. She is responsible for managing the philanthropic services that Give2Asia provides to families to strengthen local communities and grassroots organizations across 25 countries in Asia.
Deborah Kan is the executive editor and founder of Being Patient, an online health platform focused on single-subject long-term diseases. Prior to founding Being Patient, she was a journalist based in Asia and worked for both The Wall Street Journal and Reuters.
Based in San Francisco’s Mission Bay neighborhood, Gladstone Institutes is an independent state-of-the-art biomedical research institution that empowers world-class scientists to find new pathways to cures for various diseases from Alzheimer’s to heart failure. Last year Gladstone celebrated 40 years dedicated to discovery.
Based in the San Francisco Bay Area, Give2Asia is an international nonprofit that serves as a strategic partner and ally working on the ground in more than 23 countries across the Asia Pacific. Their role is to strengthen the work of local organizations and mobilize support through philanthropic giving from individuals, family foundations, and corporations.
Melanie Ott helped shape recommendations for a unified plan to end the pandemicGladstone Experts COVID-19 Ott Lab